Biological effects of electromagnetic fields and recently updated safety guidelines for strong static magnetic fields

Magnetic Resonance in Medical Sciences

Volumn 10, Issue 1, 2011, Pages 1-10

  Yamaguchi Sekino, Sachiko ^a   Sekino, Masaki ^b   Ueno, Shoogo ^c,d  

^a NATL INSTITUTE OF INDUSTRIAL HEALTH   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d TEIKYO UNIVERSITY   (Japan)

Author keywords

ICNIRP guidelines; Safety survey; Static and time varying electromagnetic fields

Indexed keywords

CELL DEATH; ELECTROMAGNETIC FIELD; ENVIRONMENTAL EXPOSURE; EQUIPMENT DESIGN; HUMAN; INSTRUMENTATION; MAGNETOTHERAPY; METHODOLOGY; MOTION; NEOPLASM; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; RADIATION EXPOSURE; REVIEW; SAFETY; STANDARD; TEMPERATURE;

CELL DEATH; ELECTROMAGNETIC FIELDS; ENVIRONMENTAL EXPOSURE; EQUIPMENT DESIGN; GUIDELINES AS TOPIC; HUMANS; MAGNETIC FIELD THERAPY; MOTION; NEOPLASMS; OCCUPATIONAL EXPOSURE; SAFETY; TEMPERATURE;

EID: 79960947752     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.10.1     Document Type: Review

References (60)

1. Environmental Health Criteria 232, Static fields. Monograph. Geneva: World Health Organization, 2006.
2. Environmental Health Criteria 238, Extremely low frequency fields. Monograph. Geneva: World Health Organization, 2007.
3. Barnes T, Greenebaum B, eds. Handbook of biological Effects of electromagnetic fields, third edition. Boca Raton: CRC Press, 2006.
4. Ueno S. Biological Effects of magnetic and electromagnetic fields. Jap J Magn Reson Med 1999; 19:289-294.
5. Berg H. Bioelectric and biomagnetic methods for cancer research and therapy-a survey. Electro-magn Biol Med 2005; 24:423-440.
6. International Commission on Non-onizing Radiation Protection. Guidelines on limits of exposure to static magnetic fields. Health Physics Society 2009; 96:504-514.
7. International Commission on Non-Ionizing Radiation Protection. Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz). Health Physics Society 1998; 74:494-522.
8. Schenck JF, Dumoulin CL, Redington RW, Kres-sel HY, Elliott RT, McDougall IL. Human exposure to 4.0-Tesla magnetic fields in a whole-body scanner. Med Phys 1992; 19:1089-1098.
9. Chakeres DW, de Vocht F. Static magnetic field Effects on human subjects related to magnetic resonance imaging systems. Prog Biophys Mol Biol 2005; 87:255-265.
10. de Vocht F, van Drooge H, Engels H, Kromhout H. Exposure, health complaints and cognitive performance among employees of an MRI scanners manufacturing department. J Magn Reson Imag 2006; 23:197-204.
11. Ueno S, Shigemitsu T. Biological Effects of static magnetic field, In: Barnes FS, Greenebaum B, eds. Handbook of biological Effects of electromagnetic fields, third edition. Boca Raton: CRC Press, 2006; 203-259.
12. Kinouchi Y, Yamaguchi Y, Tenforde TS. Theoretical analysis of magnetic field interactions with aortic blood flow. Bioelectromagnetics 1996; 17:21-32.
13. Atkinson IC, Renteria L, Burd H, Pliskin NH, Thulborn KR. Safety of human MRI at static fields above the FDA 8T guideline: sodium imaging at 9.4T does not affect vital signs or cognitive ability. J Magn Reson Imag 2007; 26:1222-1227.
14. Kangarlu A, Robitaille P-L. Biological Effects and health implications in magnetic resonance imaging. Magn Reson 2000; 12:321-359.
15. Kotani H, Kawaguchi H, Shimoaka T, et al. Strong static magnetic field stimulates bone formation to a definite orientation in vitro and in vivo. J Bone Miner Res 2002; 17:1814-1821.
16. Eguchi Y, Ogiue-Ikeda M, Ueno S. Control of orientation of rat Schwann cells using an 8-T static magnetic field. Neurosci Lett 2003; 351:130-132.
17. Schulten K. Magnetic field Effects in chemistry and biology. Adv Solid-State Phys 1982; 22:61-83.
18. Grissom CB. Magnetic field Effects in biology: a survey of possible mechanisms with emphasis on radical-pair recombination. Chem Rev 1995; 95: 3-24.
19. Nagakura S, Hayashi H, Azumi T. Dynamic spin chemistry: magnetic controls and spin dynamics of chemical reactions. Tokyo and New York: Kodan-sha and John Wiley, 1998.
20. Epstein CM, Sekino M, Yamaguchi K, Kamiya S, Ueno S. Asymmetries of prefrontal cortex in human episodic memory: Effects of transcranial magnetic stimulation on learning abstract patterns. Neurosci Lett 2002; 320:5-8.
21. Edwards MJ, Talelli P, Rothwell JC. Clinical applications of transcranial magnetic stimulation in patients with movement disorders. Lancet Neurol 2008; 7:827-840.
22. Fujiki M, Kobayashi H, Abe T, Kamida T. Repetitive transcranial magnetic stimulation for protection against delayed neuronal death induced by transient ischemia. J Neurosurg 2003; 99:1063-1069.
23. Saitoh Y, Hirayama A, Kishima H, et al. Reduction of intractable deaŠerentation pain due to spinal cord or peripheral lesion by high-frequency repetitive transcranial magnetic stimulation of the primary motor cortex. J Neurosurg 2007; 107:555-559.
24. Nagaoka T, Watanabe S, Sakurai K, et al. Development of realistic high-resolution whole-body voxel models of Japanese adult males and females of average height and weight, and application of models to radio-frequency electromagnetic-field dosimetry. Phys Med Biol 2004; 49:1-15.
25. Database of the electric properties of biological tissues at arbitrary frequencies. http://niremf.ifac.cnr.it/tissprop/
26. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985; 1:1106-1107.
27. Ueno S, Tashiro T, Harada K. Localized stimulation of neural tissues in the brain by means of a paired configuration of time-varying magnetic fields. J Appl Phys 1988; 64:5862-5864.
28. Ueno S, Matsuda T, Fujiki M. Functional mapping of the human motor cortex obtained by focal and vectorial magnetic stimulation of the brain. IEEE Trans Magn 1990; 26:1539-1544.
29. Cracco RQ, Cracco JB, Maccabee PJ, Amassian VE. Cerebral function revealed by transcranial magnetic stimulation. J Neurosci Methods 1999; 86:209-219.
30. Grafman J, Wassermann E. Transcranial magnetic stimulation can measure and modulate learning and memory. Neuropsychologia 1999; 37:159-167.
31. Bailey CJ, Karhu J, Ilmoniemi RJ. Transcranial magnetic stimulation as a tool for cognitive studies. Scand J Psychol 2001; 42:297-305.
32. Yamaguchi S, Sato Y, Sekino M, Ueno S. Combination Effects of the repetitive pulsed magnetic stimulation and the anticancer agent Imatinib on human leukemia cell line TCC-S. IEEE Trans Magn 2006; 42:3581-3583.
33. Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243:290-293.
34. Kawasaki ES, Clark SS, Coyne MY, et al. Diagnosis of chronic myeloid and acute lymphocytic leu-kemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988; 85:5698-5702.
35. Druker BJ, Lydon NB. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest 2000; 105:3-7.
36. Sekino M, Ueno S. FEM-based determination of optimum current distribution in transcranial magnetic stimulation as an alternative to electroconvul-sive therapy. IEEE Trans Magn 2004; 40: 2167-2169.
37. Yamaguchi S, Ogiue-Ikeda M, Sekino M, Ueno S. Effects of pulsed magnetic stimulation on tumor development and immune functions in mice. Bio-electromagnetics 2006; 27:64-72.
38. Yamaguchi S, Sato Y, Sekino M, Abe Y, Ueno S. Combination Effects of pulsed magnetic stimulation (MS) and imatinib mesylate (IM) on IM-resistant leukemic cells. URSI General Assembly 2008; KP2.5.
39. Ye H, Cotic M, Kang EE, Fehlings MG, Carlen PL. Transmembrane potential induced on the internal organelle by a time-varying magnetic field: a model study. J Neuroeng Rehabil 2010; 7:12.
40. Dimroth P, Kaim G, Matthey U. Crucial role of the membrane potential for ATP synthesis by F(1)F(o) ATP synthases. J Exp Biol 2000; 203: 51-59.
41. Feng HL, Yan L, Cui LY. Effects of repetitive transcranial magnetic stimulation on adenosine triphosphate content and microtubule associated protein-2 expression after cerebral ischemia-reper-fusion injury in rat brain. Chin Med J (Engl) 2008; 121:1307-1312.
42. Yamashita K, Saito M. Effects of middle-level static magnetic field on metabolic activity of mitochondria. Electr Eng Jpn 2001; 137:36-41.
43. Valdez LB, Zaobornyj T, Boveris A. Mitochondrial metabolic states and membrane potential modulate mtNOS activity. Biochim Biophys Acta 2006; 1757:166-172.
44. Belyavskaya NA. Biological Effects due to weak magnetic field on plants. Adv Space Res 2004; 34: 1566-1574.
45. Radeva M, Berg H. Differences in lethality between cancer cells and human lymphocytes caused by LF-electromagnetic fields. Bioelectromagnetics 2004; 25:503-507.
46. Aldinucci C, Garcia JB, Palmi M, et al. The Effect of strong static magnetic field on lymphocytes. Bioelectromagnetics 2003; 24:109-117.
47. Wada H, Sekino M, Ohsaki H, Hisatsune T, Ikehira H, Kiyoshi T. Prospect of high-field MRI. IEEE Transactions on Applied Superconductivity 2010; 20:115-122.
48. Shellock FG, Kanal E, Magnetic resonance: bioef-fects, safety, and patient management. New York, USA: Lippincott Williams & Wilkins, 1996.
49. Ordidge RJ, Shellock FG, Kanal E. A Y 2000 update of current safety issues related to MRI. J Magn Reson Imaging 2000; 12:1.
50. US Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health. Guidance for industry and FDA staŠ: criteria for significant risk investigations of magnetic resonance diagnostic devices 2003.
51. International Commission on Non-Ionizing Radiation Protection. Medical magnetic resonance (MR) procedures: protection of patients. Health Phy 2004: 87:197-216.
52. International Commission on Non-Ionizing Radiation Protection.Amendment to the ICNIRP "State-ment on medical magnetic resonance procedures: protection of patients." Health Phys 2009; 97: 259-261.
53. International Commission on Non-Ionizing Radiation Protection. Guidelines on limits of exposure to static magnetic fields. Health Phys 1994; 66: 100-106.
54. Chakeres DW, Kangarlu A, Boudoulas H, Young DC. Effect of static magnetic field exposure of up to 8 Tesla on sequential human vital sign measurements. J Magn Reson Imaging 2003; 18:346-352.
55. Chakeres DW, Bornstein R, Kangarlu A. Randomized comparison of cognitive function in humans at 0 and 8 tesla. J Magn Reson Imaging 2003; 18:342-345.
56. Glover PM, Cavin I, Qian R, Bowtell R, Gowland PA. Magnetic field-induced vertigo: a theoretical and experimental investigation. Bioelectromagnet-ics 2007; 28:349-361.
57. Kangarlu A, Burgess RE, Zhu H, et al. Cognitive, cardiac, and physiological safety studies in ultra high field magnetic resonance imaging. Magn Res-on Imaging 1999; 17:1407-1416.
58. Volkow ND, Wang GJ, Fowler JS, Rooney WD, Felder CA, Lee JH, Franceschi D, Maynard L, Schlyer DJ, Pan JW, Gatley SJ, Springer Jr CS. Resting brain metabolic activity in a 4 tesla magnetic field. Magn Reson Med 2000; 44:701-705.
59. Schlamann M, Yoon MS, Maderwald S, Pietrzyk T, Bitz AK, Gerwig M, Forsting M, Ladd SC, Ladd ME, Kastrup O. Short term Effects of magnetic resonance imaging on excitability of the motor cortex at 1.5T and 7T. Acad Radiol; 17: 277- 281.
60. Weikl A, Moshage W, Hentschel D, Schittenhelm R, Bachmann K. [ECG changes caused by the Effect of static magnetic fields of nuclear magnetic resonance tomography using magnets with a field power of 0.5 to 4.0 Tesla]. Z Kardiol 1989; 78: 578-586.